Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 2820
Epidemiology: Open Access received 2820 citations as per Google Scholar report
Epidemiology: Open Access peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- SafetyLit
- Access to Global Online Research in Agriculture (AGORA)
- Centre for Agriculture and Biosciences International (CABI)
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- CABI full text
- Cab direct
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Approaches towards TB control – from lab to clinics
3rd International Conference on Epidemiology & Public Health
Parul Chakrabarti
Posters-Accepted Abstracts: Epidemiology (Sunnyvale)
Abstract
Tuberculosis (TB) is a world - wide problem and India is one of the worst effected countries. However TB is a curable disease
if it is detected early and treated with sensitive drugs. The causative agent, Mycobacterium tuberculosis, has been found to
sleep for 100, 000 years in the skull of homosapiens. The organism often evolves as drug - resistant strains, multidrug-resistant
(MDR) (resistant at least to two TB drugs - rifampicin and isoniazid), and extensively drug - resistant (XDR) (additionally
resistant to a fluoroquinolone and kanamycin/amikacin/capreomycin) due to non-adherence to treatment or treatment with
insensitive drugs. Alarming incidences of drug resistance and HIV co-infection pose a major threat to TB control efforts. Early
easy cost effective detection, drug sensitivity test (DST) and strategic approaches towards target identification for therapeutic
intervention, are required to combat the disease. Our initiatives in these areas will be discussed.
